AI assistant
Sending…
Calliditas Therapeutics — Major Shareholding Notification 2021
Nov 16, 2021
3020_iss_2021-11-16_c25d8525-8f26-4145-9d42-580aab93dc17.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer Calliditas Therapeutics AB
Holder
Handelsbanken Fonder AB
Instrument
| Instrument | Aktie SE0010441584 | |
|---|---|---|
| Before the transaction | ||
| Shares | 2,637,155 | |
| Voting rights | 2,637,155 | |
| Transaction | ||
| Reason for major shareholding notification Sell | ||
| Date | 15/11/2021 | |
| Limit for number of shares | 5 % | |
| Limit for number of votes | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 2,561,188 | |
| Directly held voting rights | 2,561,188 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 4.89 % | |
| Directly held voting rights | 4.89 % | |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 4.89 % | 2,561,188 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 4.89 % | 2,561,188 |
| Published 16/11/2021 15:29 |
||
| Contact | ||
| Name Gustav Lindberg Phone 087011417 |
Email [email protected] |
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Calliditas Therapeutics
Board/Management Information
2024
Sep 30
Declaration of Voting Results & Voting Rights Announcements
2024
Sep 30
Delisting Announcement
2024
Sep 16
Delisting Announcement
2024
Sep 16
Major Shareholding Notification
2024
Sep 13
Major Shareholding Notification
2024
Sep 3
Major Shareholding Notification
2024
Sep 3
Delisting Announcement
2024
Sep 3
Delisting Announcement
2024
Sep 3
Proxy Solicitation & Information Statement
2024
Sep 3